跳至主要内容
临床试验/NCT01360229
NCT01360229已完成不适用

Acupuncture as a Symptomatic Treatment for Fatigue in Parkinson's Disease

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2010年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
94
试验地点
2
主要终点
Change in the Modified Fatigue Impact Scale Total (MFIS) Between Treatment Groups

研究概览

简要总结

This is a single-center, double-blind, placebo-controlled trial to see if acupuncture can safety and effectively treat fatigue in Parkinson's Disease (PD). Eligible subjects will receive either real or sham acupuncture twice weekly for six weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with PD
  • Patients 40-99 years of age
  • Patients who have significant fatigue
  • Patients must be on a stable medication regimen for the treatment of PD

排除标准

  • Patients who have had previous acupuncture within the past six months
  • Patients who have had deep brain stimulation (DBS)
  • Patients with dementia, depression, or sleep disorder
  • Patients who are currently taking medications known to affect fatigue, such as stimulants

研究组 & 干预措施

Randomized Subjects receive a sham acupuncture.

Sham Comparator

Subjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.

干预措施: Acupuncture to treat fatigue in Parkinson disease (Other)

Randomized Subjects receive real acupuncture.

Active Comparator

Subjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.

干预措施: Acupuncture (Procedure)

结局指标

主要结局

Change in the Modified Fatigue Impact Scale Total (MFIS) Between Treatment Groups

时间窗: 6 weeks

The primary outcome measure will be the change between the baseline visit and 6-week time point in the Modified Fatigue Impact Scale Total (MFIS) between treatment groups. The range of the score is 0-84 with higher scores reflecting more severe fatigue.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验